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Carboxylesterases (CEs) metabolize a wide range of endogenous
compounds and xenobiotics containing ester bonds. Crystal structures of
mammalian CEs indicate a ‘side door’ located adjacent to the catalytic gorge
that may act as an alternative pore for the trafficking of substrates and products.
This study investigated the role of the ‘gate’ residue of the side door during
para-Nitrobenzyl esterase (pnb CE)-catalyzed hydrolysis of esters. Purified
recombinant pnb CE proteins were examined for their hydrolytic activity toward
several esters. Mutation of the gate residue altered the kinetic parameters of
pnb CE toward these substrates, demonstrated by increased Km values and
decreased Vmax values. Site-specific mutations of the ‘gate’ residue also
affected the sensitivity of the enzyme toward inhibiting organophosphate
compounds. A distinct possibility is that the side door mutants affect substrate

hydrolysis by increasing the steric hindrance and/or electrostatic repulsion
between the substrate and the active site catalytic residues.
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CHAPTER I
INTRODUCTION

Carboxylesterases (CEs) are enzymes involved in the metabolic
degradation of many exogenous esters. Upon ingestion and absorption, foreign
compounds containing ester bonds undergo first pass metabolism in the small
intestine and liver, two tissues that express CEs at high levels. Hence, this
enzyme class is an attractive target for drug therapies. For example, CEs have
potential roles in drug overdose prevention, pro-drug therapy, and as a
prophylactic against nerve agents (Redinbo and Potter, 2005). Moreover, CEs
have important roles in the hydrolysis of pesticides, drugs, pro-drugs, and
endogenous esters (Satoh and Hosokawa, 1998). Thus, CE-catalyzed
hydrolytic metabolism influences the half-life of many foreign esterified
compounds in the body.
How CEs recognize their substrates and catalyze hydrolysis of ester
bonds is not fully understood. Further understanding the molecular mechanism
of CE-mediated hydrolysis of esters will allow for the optimization of CEs in
processing drugs and environmental compounds. Development of selective
inhibitors of CEs may improve the distribution of pro-drugs that are activated by
1

CEs and ameliorate pesticide resistance in insects that over-express CEs.
However, it is first necessary to understand the fundamental basis of hydrolytic
metabolism by CEs.
This study addresses the role of the CE side-door in catalysis.
Compounds have been shown to interact with three distinct regions of CEs.
These include the ligand binding pocket in the active site, an allosteric Z-site on
the enzyme surface and the side-door adjacent to the active site. Metabolites
formed during catalysis are bound at the side door, implicating the side door as
an entrance and/or exit pore for substrates and products (Bencharit et al., 2002;
Bencharit et al., 2006). Site-directed mutations of side door residues have been
shown to alter substrate affinity and reaction rates (Wierdl et al., 2004).
In this study, we have utilized the Bacillus subtilis p-nitrobenzyl esterase
(pnb CE) as a model enzyme to study the structure-function relationship of Ces
and to lay the foundation for future studies into mammalian enzymes. We have
extended the work of Wierdl et al. by examining six different amino acid
substitutions at Leu 362, including two positively charged (L362D, L362E), two
negatively charged (L362K, L362R), and two neutral and aliphatic (L362A and
L362V) residues for activity toward pNPV, 4-MUBA, trans-permethrin and
selected OP oxons. Altered kinetic parameters in the hydrolysis of several
esters were observed by site-specific mutants at the side-door of pnb CE.
Examination of individual rate constants of CE-catalyzed hydrolysis indicated

2

that many steps are controlled by side door residues, including substrate
association and the acylation and deacylation rates.

3

CHAPTER II
LITERATURE REVIEW

Carboxylesterases (CEs, EC. 3.1.1.1) are a large class of serine
hydrolyses ubiquitously expressed throughout the animal kingdom that are
defined by their ability to catalyze the hydrolysis of ester, amide, and thioester
bonds of endogenous and exogenous compounds (Satoh and Hosokawa,
1998). Examples of exogenous substrates include drugs, pesticides,
environmental compounds, and food additives. Endogenous substances for
CEs include short and long chain acyl-glycerols, long chain acyl-carnitines, long
chain acyl-CoA esters, and steroids.
The pyrethroids insecticides are esterified compounds that are detoxified
by CEs in mammals and insects. Commercial pyrethroids are derived from the
natural pyrethrins, which were isolated from Chysanthemum cinerariaefolium
flower heads. This class of organic pesticide is becoming an ever more popular
choice of insect control due to its high insecticidal toxicity and minimal
mammalian toxicity. Pyrethroid toxicity is elicited by its ability to induce
neuronal hyper-excitability. Specifically, the pyrethroids bind to Na+-channels
causing a prolonged channel opening which raises the tail currents of action
4

potentials (Narahashi 1992). While acute pyrethroids toxicity in mammals is
low, their ability to induce detoxification enzymes may be important in pesticidepesticide or pesticide-drug interactions.
Pyrethroid pesticide-pesticide/drug interactions have been confirmed by
recent research showing that these compounds and their metabolites are
inducers of xenobiotic metabolizing enzymes. Both parent pyrethroids and their
metabolites have been shown to induce xenobiotic metabolizing enzymes. For
example, permethrin is a potent inducer of CYP 2B1 and fenvaleric acid
induces several phase I enzymes including CE (Heder et al., 2001; Morisseau
et al., 1999). One mechanism of induction may be attributed to the liganddependent activation of the xeno-sensing pregnane X receptor (PXR)
transcription factor. PXR induces enzymes belonging to all phases (I-III) of
xenobiotic metabolism, including the pharmacologically relevant CYP 3A4
enzyme that metabolizes 50% of all clinical drugs (Maglich et al., 2002;
Rosenfeld et al., 2003; Guengerich, 1999). The pyrethroids cypermethrin,
fenvalerate, and permethrin have been shown to be potent activators of PXR in
cell lines stably transfected with PXR, but elicit more modest responses in
human hepatocytes (Lamaire et al., 2004; Lamaire et al., 2006).
CEs are expressed throughout the human body including the liver, small
intestine, brain, stomach, colon, macrophages, and monocytes (Satoh and
Hosokawa, 1998). Three human isoforms have been cloned and purified and
are termed hCE1, hCE2 and hCE3. The highest expression levels of these
5

isoforms are found in the liver, small intestine, and brain, respectively. CEs are
present in both the microsomal and cytosolic fractions of cells. Retention of the
CEs in the endoplasmic reticulum is dependent upon the presence of an ER
retention tetrapeptide on the C-terminus (Satoh and Hosokawa, 1998; Pelham,
1990).
The pathophysiological functions of CEs encompass xenobiotic
metabolism, cholesterol homeostasis, and synthesis of fatty acid ethyl esters
(FAEE). CE-mediated xenobiotic metabolism involves several classes of
insecticide substrates including pyrethroids and carbamates. Moreover,
detoxification of organophosphate (OP) insecticides is considered to be
mediated by the scavenger mechanism of CEs in which the active-site Ser
residue of CEs covalently reacts with the oxons and, in the process, inactivates
the compound before it can reach its nervous system targets (Sogorb and
Vilanova, 2002). CEs are also involved in the bioactivation of pro-drugs, such
as the cholesterol lowering drug lovastatin and the chemotherapeutic agent
CPT-11 (Tang and Kalow, 1995; Satoh et al., 1994). Non-therapeutic
bioactivation reactions are also catalyzed by CEs. An example is the transesterification of cocaine with ethanol, which produces the highly hepatotoxic
compound cocaethylene (Brzezinski et al., 1994).
CEs are involved in cholesterol homeostasis, the balance between
stored cholesteryl esters and free metabolically available cholesterol and fatty
acids. Cholesterol homeostasis consists of two separate but opposing
6

reactions. (i) The trans-esterification of cholesterol with fatty acids to yield
cholesteryl esters, catalyzed by an acyl-Coenzyme A:cholesterol
acyltransferase (ACAT) activity (Becker et al., 1994). (ii) The hydrolysis of
cholesteryl esters producing free fatty acids and cholesterol, referred to as
cholesteryl ester hydrolase (CEH) activity (Zhao et al., 2005). Improper
cholesterol homeostasis in macrophages can lead to the progression of
atherosclerosis. This occurs when an excess of cholesteryl esters in
macrophages builds up and potentiates the conversion of macrophages to foam
cells, thus resulting in fatty streaks in the arterial wall (Li and Glass, 2005).
Similar in mechanism to the synthesis of cholesteryl esters, hepatotoxic
FAEEs are formed by CE-mediated trans-esterification of free fatty acids with
ethanol (Kaphalia and Ansari, 2001). FAEEs are known to uncouple oxidative
phosphorylation and chronic exposure to these compounds can result in
necrotic tissue decay (Lange and Sobel, 1983). Due to the relatively large size
of the fatty acid substrates involved in the trans-esterification reactions the side
door has been proposed to act as an alternative entrance for substrates into the
active site from the enzyme surface. This role of the side door in the utilization
of fatty acid substrates is supported by a crystallized structure of hCE1, which
includes palmitic acid bound at the side door (Bencharit et al., 2006).
Throughout the CE family of enzymes several domains are highly
conserved, including the active site catalytic residues (Glu, His and Ser), four
Cys residues involved in disulfide bonds, and two Gly residues that form an
7

oxyanion hole and stabilize the tetrahedral intermediate produced during the
hydrolytic reaction (Cygler et al., 1993). Mutation of active site residues
confirmed that a charge relay system is used in the deprotonation/activation of
the Ser residue (Satoh and Hosokawa, 1998). Figure 1 describes the catalytic
mechanism. Hydrolysis of ester bonds occurs by (i) nucleophilic attack on the
ester carbonyl carbon by the activated Ser residue, forming a tetrahedral
intermediate. The alcohol product is then released by (ii) deprotonation of the
active His residue with concomitant formation of an acyl-enzyme intermediate.
(iii) Deacylation of the enzyme then occurs by nucleophilic attack by a water
molecule, which reforms a tetrahedral intermediate that collapses releasing the
carboxylic acid product in the process (Satoh and Hosokawa, 1998).
Recent crystallographic studies of mammalian CEs have proposed the
existence of a side-door in CEs that acts as an entrance and/or exit pore for
substrates and products (Bencharit et al., 2002; Bencharit et al., 2006). The
side door is located at the deepest region of the substrate binding pocket and
consists of a pore that is restricted by neighboring residues. An alternate route
to the catalytic residues within the active site is not unique to carboxylesterase
enzymes. For example, it has also been observed in structures of bovine bile
salt-activated lipase (bBAL) and acetylcholinesterase (AChE), with the
suggested “back door” of AChE located 180º from the proposed location of the
CE side door (Bencharit et al., 2002; Terzyan et al., 2000; Bartolucci et al.,
1999). The side door is one of three structural domains of CEs that can interact
8

with ligands. The others include the active site and an allosteric Z-site (Redinbo
and Potter, 2005).
Due to the convenience of expressing recombinant site-directed mutant
proteins in Escherichia coli, the para-nitrobenzyl esterase (pnb CE) from
Bacillus subtilis was previously used as a model enzyme to study the structurefunction of CEs (Wierdl et al., 2004). In contrast to mammalian CEs that need
to be glycosylated to be functionally active, the B. subtilis pnb CE does not
require post-translational modification. pnb CE is an excellent model of the
mammalian CEs since it exhibits close structural homology and similar catalytic
activities. For example, both pnb CE and a rabbit CE exhibited comparable
specific activities using the substrates ortho-nitrophenyl acetate (oNPA) and
CPT-11 (a chemotherapeutic prodrug) (Wierdl et al., 2004). Mutations of sidedoor residues in both rabbit CE and pnb CE similarly reduced catalytic activity
toward these substrates. It was further shown that the size and charge of the
mutated residue in the side-door can significantly impact enzyme activity. For
example, substitution of Ser 218 of pnb CE with alternative residues
demonstrated that the size of the amino acid side chain was a primary
determinant of enzyme activity, while substitution of Leu 362 with positively
charged residues significantly reduced enzyme activity (Wierdl et al., 2004).
The most detrimental effects were observed when the leucine at position 362
was substituted with an arginine residue (L362R). Specifically, the L362R
mutants exhibited 8- and 170-fold lower catalytic efficiency (kcat/Km) compared
9

to wild-type enzyme when the hydrolysis rates of oNPA and CPT-11 were
examined, respectively (Wierdl et al., 2004). Furthermore, the L362R mutant
exhibited a 137-fold lower substrate association rate (k1) than the wild type
enzyme with CPT-11 as a substrate.
In this study, we have further investigated the role of the Leu 362 residue
in the side-door of pnb CE. Leu 362 of pnb CE is analogous to the side-door
‘gate’ residues of mammalian CEs, including Met 425 of human
carboxylesterase isoform 1 (hCE1) (Bencharit et al., 2006). Mutated gate
residues have been shown to alter the hydrolytic activity of CEs and are
associated with species differences in the substrate preferences of mammalian
CEs (Wierdl et al., 2004; Wallace et al., 2001). For example, the gate residue
Met425 of hCE1 may control fatty acid release following cholesteryl ester and
fatty acyl-CoA hydrolysis (Bencharit et al., 2006). Furthermore, mutational
analysis of the rat carboxylesterase, Hydrolase A, demonstrated this residues
involvement in shifting substrate preference to cholesteryl esters and assuming
CEH activity (Wallace et al., 2001). This current study offers insight into the
altered kinetic parameters observed between the wild type pnb CE enzyme and
side-door mutants.
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CHAPTER III
MATERIALS AND METHODS

Reagents, chemicals and materials
Rifampicin was obtained from Sigma-Aldrich (St. Louis, MO). FuGene 6,
the renilla expression vector (pRL-TK), and the Dual Luciferase reporter assay
system were obtained from Promega (Madison, WI). The PXR expression
plasmid, pCDG1-SXR, was kindly provided by Dr. R. Evans, Salk Institute.
pGL3-CYP3A4(-7830Δ7208_364) (Hustert et al., 2001), the luciferase vector
under control of the CYP3A4 proximal and distal promoter was generously
provided by Dr. O. Burk, Dr. Margarete Fischer-Bosch-Institute of Clinical
Pharmacology. The Hep G2 cell line, the culture media and FBS were obtained
from ATCC (Manassas, VA). Hep G2 cells were cultured in a humidified
incubator at 37° C, 95 % air and 5 % CO2. Cells were grown in Eagle’s
Minimum Essential Medium (MEM) supplemented with 10% FBS, 100 U/ml
penicillin and 100 μg/ml streptomycin (Sigma-Aldrich).
The gene for wild type pnb CE or site-directed mutants were inserted into
a pTriEx-3 expression vector and transformed into E. coli Origami B cells
(Wierdl et al, 2004). Bugbuster reagent was purchased from Novagen
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(Madison, WI). An Ostwald viscometer (Cat # 13695) was purchased from
Barnstead International (Dubuque, IA). Pyrethroids were obtained from Chem
Service (West Chester, PA). p-Nitrophenyl valerate and o-nitrophenyl acetate
were synthesized and kindly provided by Dr. Howard Chambers (Department of
Entomology and Plant Pathology, Mississippi State University) as were the
organophosphates methyl paraoxon, paraoxon and chlorpyrifos oxon.

Dual-luciferase assay
The transfection method was based on a published method describing a
dual-luciferase assay in the HepG2 cell line (Chang and Waxman, 2005).
HepG2 cells were seeded into a 12-well plate at a density of ~500,000
cells/well. Upon reaching 50-80% confluence (~1 day post-seeding) the cells
were co-transfected with pGL3-CYP3A4, pCDG1-SXR, and pRL-TK plasmids.
The transfection reagent FuGene 6 and plasmid DNA were mixed and
incubated together according to the manufacturer’s protocol. Transfection
solutions per well consisted of the pGL3-CYP3A4, pCDG1-SXR, and pRL-TK
plasmids in the amounts of 360, 90, and 10 ng, respectively, along with 540 ng
sonicated salmon sperm DNA to reach a total DNA amount of 1 μg. In select
cases, HepG2 cells were mock transfected with PXR expression vector to
evaluate PXR dependence of treatments.
Cells were transfected for 24 hr and the culture medium was removed.
Cells were then treated for 24 hr with fresh medium containing 10 μM of
13

selected pyrethroids compounds or the stereo-typical PXR ligand, rifampicin
(the amount of DMSO vehicle in the medium was 0.1% v/v). Control treatments
contained only DMSO spiked into fresh medium (0.1% v/v). Following
treatment, the culture medium was removed and the cells were washed twice
with PBS prior to being lysed with 250 μl of passive lysis buffer (Promega).
Lysates were stored at -20° C until the luciferase activity assays were
performed.
To measure the firefly luciferase activity of the lysates, 30 μl of luciferase
assay reagent II (Promega) was mixed with 5 μl of lysate and luminescence
was measured using TD–20/20 luminometer (Turner Designs). The firefly
luciferase reaction was quenched by the addition of 30 μl of Stop and Glo
reagent (Promega) followed by detection of luminescence derived from the
renilla luciferase activity. Firefly luciferase activity was normalized to the renilla
activity in each sample. Three independent transfections were performed with
triplicate treatments for each compound (n = 9). Fold induction over DMSO was
averaged for each compound.

Expression and purification of wild type and L362 mutant pnb CEs
Expression of pnb CE wild type and site specific mutants of pnb CE in E.
coli was performed similar to Wierdl et al. (2004). Briefly, 5-ml fresh LB medium
supplemented with antibiotics was inoculated 1:100 with transformed cells and
grown overnight at 37º C in an orbital shaking incubator. This overnight culture
14

was transferred to 250 ml of fresh medium and cultured at 37° C until an OD600
of ~0.35-0.40 was reached (~ 3 to 4 hrs). At this point, expression of the
recombinant protein was induced by addition of 1 mM isopropyl β-D-1thiogalactopyranoside (IPTG). The induced culture was incubated overnight
and the cells were harvested by centrifugation (6,000 x g, 4° C) the following
day. The harvested cells were lysed by adding 10 volumes of Bugbuster
reagent and the lysate was centrifuged at 16,000 x g (4°C) for 10 minutes to
remove cell debris. Following centrifugation, the supernatant was collected and
dialyzed over 48 hours in 1 L of 10 mM Hepes (pH 7.4) buffer (2 x 24 hrs, fresh
buffer was added after 24 hrs). The protein content of the dialyzed protein
extract was determined using BCA reagent (Pierce; Rockford, IL).
A Bio-Rad Prep Cell 491 was used to purify the pnb CE variants by
native PAGE. A 4% stacking gel (~1.8 cm height) and a 10% resolving gel
(~3.2 cm height) was used to separate proteins. Collected fractions (2.5 ml)
were tested for the presence of esterase activity by a previously described
native in-gel hydrolysis assay using the substrate 4-methylumbelliferyl acetate
(4-MUBA) (Ross et al., 2006). Protein purity of collected fractions was
determined by SDS-PAGE and Sypro Ruby staining. Fractions containing pure
CE protein and esterase activity were pooled, concentrated and the elution
buffer was exchanged with 50 mM Tris-HCl (pH 7.4) storage buffer. To confirm
the presence of mutant Arg or Lys residues at position 362, purified proteins
were excised from an SDS-PAGE gel, digested with trypsin and analyzed by
15

MALDI-TOF MS/MS (Life Sciences Biotechnology Institute, Mississippi State
University). Trypsin selectively hydrolyzes peptide bonds after a lysine or
arginine residue. Therefore, the introduction of the lysine and arginine residues
at position 362 theoretically creates an additional site for trypsin to cleave pnb
CE.

Hydrolysis analysis of esters
Known substrates of CEs consist of a large array of compounds. In this
study three types of substrates were chosen due to the relatively easy detection
of their metabolites. The acyl-substituted nitrophenolic esters are standard
substrates for CEs and when hydrolyzed release nitrophenol that can be
quantified spectrophotometrically. Other esters chosen to examine also have
readily detectable metabolites including; 4-methylumbelliferyl acetate which
releases a fluorescent product (4-methylumbelliferone) when hydrolyzed, and
the insecticide trans-permethrin whose metabolites are detected by HPLC with
ultraviolet detection.
p-Nitrophenyl valerate (pNPV), p-nitrophenyl acetate (pNPA), and o-nitrophenyl
acetate (oNPA) hydrolysis reactions
Hydrolysis reactions were performed in a clear 96-well plate format with
enzyme (wild type or mutant) diluted to 0.2-0.5 μg protein/ml and substrate
concentrations ranging from 0-1000 μM. The acyl-ester substrates, dissolved in
ethanol, were diluted into 50 mM Tris-HCl (pH 7.4) buffer at the appropriate
16

concentrations and 225 μl of the substrate solutions were added to wells in
triplicate. After a 5 min pre-incubation at 37° C, the reaction was initiated by the
addition of 75 μl of diluted enzyme (prepared in 50 mM Tris-HCl, pH 7.4, buffer).
Reaction progress was monitored spectrophotometrically at 405 nm over 5 min
to estimate the rate nitrophenol formation. The slopes of the activity curves
(absorbance units per minute) were recorded. Reactions were performed in
triplicate. Data was converted to enzyme activity units (i.e., μmol of nitrophenol
formed/min/mg protein) using an extinction coefficient of 13mM-1cm-1.
4-Methylumbelliferyl acetate (4-MUBA) hydrolysis reactions
Reactions were performed in black 96-well plates with clear bottoms.
Enzyme concentrations of 0.2-0.5 μg protein/ml were used along with final 4MUBA concentrations ranging from 7.5 to 562.5 μM. Substrate was dissolved
in acetonitrile and diluted into 50 mM Tris-HCl (pH 7.4) buffer at the appropriate
concentrations with 150 μl aliquots added to wells in triplicate. After a 5 min
pre-incubation at 37° C, reactions were initiated by the addition of 50 μl dilute
enzyme. The fluorescence of the hydrolysis product, 4-methyl umbelliferone (4MUB), was monitored for 5 min at 37° C using an excitation wavelength of 355
nm and emission wavelength of 460 nm. The average relative fluorescence
units per minute were recorded and converted to enzymatic activity (i.e. μmol of
4-MUB formed/min/mg protein) using a calibration curve for 4-MUB.
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Pyrethroid hydrolysis reactions
Preliminary studies using the synthetic pyrethroids cis- and transpermethrin, deltamethrin, alpha-cypermethrin, lambda-cyhalothrin,
esfenvalerate and bioresmethrin indicated that only trans-permethrin was
metabolized by pnb CE at an appreciable rate. The rate of trans-permethrin
hydrolysis by wild type pnb CE was found to be linear up to 30 min at 37º C.
Duplicate reactions were performed in 50 mM Tris-HCl (pH 7.4) buffer
containing substrate concentrations varying from 1.25-100 μM in a total reaction
volume of 100 μl. After pre-incubation of buffer and substrate for 3-5 min at 37°
C, reactions were initiated by the addition of 10 μg of pure pnb CE enzyme.
The reactions were quenched after a 20 min incubation with an equal volume of
acetonitrile containing 10 μM of internal standard 3-(4-methoxyphenoxy)benzaldehyde (3MPB). The reactions were subsequently placed on ice.
Samples were centrifuged at 16,000 x g (4° C) for 10 min to remove
precipitated protein prior to transferring supernatants into HPLC vials. The
supernatants were analyzed for the hydrolysis product 3-phenoxybenzyl alcohol
(3PBAlc) by HPLC (Ross et al., 2006). Enzyme activity was calculated and
expressed as pmol of 3PBAlc formed/min/mg protein.
Kinetic analysis of hydrolysis reactions
The enzymatic activity versus substrate concentration data was fit by
non-linear regression analysis to the Michaelis-Menten equation using Sigma
18

Plot v. 8.02. The kinetic parameters Vmax (maximum velocity), kcat (enzyme
turnover number), Km (Michaelis constant), and kcat/Km (catalytic efficiency)
were obtained and significant differences (p < 0.05) between wild type and
mutant enzymes were determined by ANOVA statistical analysis. Kinetic
assays were performed in triplicate (n = 9) for 4-MUBA, pNPV and pNPA.
Trans-permethrin assays were performed in duplicate (n = 4) due to the larger
amounts of enzyme required.

Inhibition of pnb CE activity by organophosphate oxons
Wild type and mutant pnb Ces were diluted to 0.2-0.5 μg protein/ml in 50
mM Tris-HCl (pH 7.4) buffer and 70 μl of the diluted enzyme solution was added
to a clear 96-well plate in triplicate. Five μl of oxon stock solutions in ethanol
were added to each well containing enzyme resulting in final oxon concentration
ranges of 0.01-100 nM for paraoxon (PO) and chlorpyrifos oxon (CPO), and 110,000 nM for methyl paraoxon (MPO). Enzyme and oxons were incubated
together at 37° C for 10 min. The enzymatic reaction was initiated by addition
of pNPV in 50 mM Tris-HCl (pH 7.4) buffer resulting in a final reaction volume
and substrate concentration of 300 μl and 500 μM, respectively. The
absorbance was monitored at 405 nm for five minutes at 37° C. Assays were
performed with two to four replications (n = 6 to 12). IC50 values for each
replication were averaged. Statistical differences between wild type and mutant
pnb CE IC50 values (p < 0.05) were determined by ANOVA analysis.
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pH profile of para-nitrophenyl laurate (pNPL) hydrolysis
Reactions with pNPL were performed similar to pNPV or pNPA
reactions. Preliminary experiments indicated high non-enzymatic hydrolysis
rates for pNPA, pNPV and 4-MUBA at pH > 8.5. Therefore, pNPL was chosen
as a substrate due to its low non-enzymatic hydrolysis rate over the pH range of
6-10.5. Buffers of varying pH were prepared with 150 mM NaCl, 0.01% Triton
X-100 and 50 mM bis-Tris, Tris or glycine for pH ranges of 5.8-7.2, 7.0-9.0 and
8.8-10.6, respectively. Stock pNPL solutions were sonicated for 10 min to
completely suspend the substrate. Substrate concentrations ranged from 0500 μM and dilute enzyme solutions were 0.5 µg protein/ml and 1.0 µg
protein/ml for wild type and L362R pnb CE, respectively. Reactions were
monitored on a multi-well plate reader, as described for pNPV and pNPA.
Regression analysis of the experimental data was performed to determine
apparent pKa values of ionizable residues involved in catalysis. Vmax data were
set to equation 1 and the V0max (the apex of the curve), pKa1, and pKa2 were
adjustable parameters (Turner el al., 2002, and Fülöp et al., 2001).
Vmax (pH) = V0max * (1 + 10pKa1-pH + 10pH-pKa2)-1

(1)

Hydrolysis reactions of pNPV, pNPA and trans-permethrin in solutions of
increasing viscosity
Solutions of 0, 7, 15, 23 and 30% sucrose (w/w) were prepared in 50 mM
Tris-HCl (pH 7.4) buffer. The density and viscosity was measured with an
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Ostwald viscometer and determined at 25° C and 37° C with the 0% sucrose
solution used as the reference (η0%). The relative viscosity (ηrel) was calculated
by equation 2, where ηo% = 1.000, ηx = viscosity at x% sucrose, d = density,
and t = time from viscometer.
Ηrel = ηx/ηo% = (dxtx / do%to%)

(2)

Enzymatic reactions in the sucrose solutions were performed at room temp (25°
C) using pNPV and pNPA, and at 37° C for trans-permethrin. Trans-permethrin
reactions were quenched with equal volumes of methanol containing internal
standard instead of acetonitrile due to its non-miscibility with sucrose solutions.

Viscosity variation analysis
The kinetic parameters of pNPV, pNPA and trans-permethrin hydrolysis
were determined in increasing solutions of sucrose. The mechanistic scheme
of pnb CE hydrolysis (Figure 3) is based upon the previously described
proposed mechanism (Satoh and Hosokawa, 1998). Enzymatic reactions can
be limited by diffusion rather than a chemical step. Therefore, it is possible to
determine if the rate-limiting step of pnb CE reactions is dependent upon (i) the
association of substrate with the active site or (ii) the release of product from
the enzyme by determining steady-state parameters in increasing
concentrations of a viscogen. A plots of relative catalytic efficiency
(kcat/Km)0/(kcat/Km) versus relative viscosity (ηrel) is able to determine if substrate
association is completely dependent upon diffusion (slope = 1), not dependent
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upon diffusion (slope = 0) or partially dependent upon diffusion (0 < slope < 1)
(Brouwer and Kirsch, 1982). In a similar fashion, plots of kcat0/kcat versus ηrel
describe a reaction’s dependence on diffusion of products away from the
enzyme active site.
Viscosity experiments are also able to experimentally derive the
substrate association rate constant of catalysis. Expressions for the first and
second order rate constants; kcat and kcat/Km are expressed by equations 3 and
4, and the reverse reactions k-2 and k-3 are assumed to be negligible (Brouwer
and Kirsch, 1982; Mattei et al., 1999).
Kcat/Km = k1k2/(k-1 + k2)

(3)

kcat = k2k3/(k2 +k3)

(4)

The rates of substrate association and product disassociation are assumed to
be diffusion dependent, therefore the rate constants k1, k-1, k2, and k3 (Figure 3)
are dependent upon the viscosity of the reaction medium (Equation 5). The
superscript 0 refers to the rate constant in the absence of viscogen.
K1 = k10/ηrel

k-1 = k-10/ηrel

k2 = k20/ηrel

k3 = k30/ηrel

where ηrel = η/η0

(5)

Substitution of these viscosity dependent rate constants (equation 5) into
equations 3 and 4 yield the following linear expressions (equations 6 and 7).
Km/kcat = 1/(kcat/Km) = k-10/(k10k20) + (1/k10)ηrel

(6)

1/kcat =[(k20+k30)/k20k30]ηrel

(7)
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Linear plots of inverse catalytic efficiency (kcat/Km) or turnover number (kcat)
versus the relative viscosity (ηrel) yield lines with slopes equal to 1/k10 and
[(k20+k30)/k20k30], respectively. From equation 6, the second order rate constant
for substrate association (k1) can be determined if substrate association is
diffusion limited (i.e. slope > 0)

Continuous carbaryl inhibition of pNPV hydrolysis
pNPV (final concentration, 500 μM) was pre-incubated with variable
concentrations of carbaryl (0-25 μM) in 1.0 ml of 50 mM Tris-HCl (pH 7.4) buffer
for 5 min (37° C). Enzymatic reactions were initiated by the addition of 10-60
ng pnb CE protein and reactions were monitored spectrophotometrically at 405
nm for the formation of nitrophenol over a period of 30 min. A biphasic activity
curve was observed during the inhibition of CE-catalyzed hydrolysis of pNPV by
carbaryl.

Analysis of carbaryl inhibition
This analysis, according to Feaster et al. (1996), allows the affinity of
carbaryl for the enzyme (Kc = k-1/k1) and the rate constants of carbamylation (k2)
and decarbamylation (k3) to be determined (Figure 4). The data were analyzed
using equation 8 (Feaster et al., 1996; Feaster and Quinn, 1997), where A0,
kobs, v0, and vss are the absorbance at t = 0, the observed first-order inhibition
rate constant, the initial velocity, and the steady-state velocity, respectively.
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A = A0 + [(v0 – vss)/kobs]*(1-e-kobs*t) + vsst.

(8)

Obtaining kobs values at each concentration of carbaryl allows the determination
of the carbamylation rate constant k2 and apparent dissociation constant Ki of
the non-covalent enzyme-carbamate complex by use of equation 9 (Feaster
and Quinn, 1997). The variable [I] represents the concentration of carbaryl.
Kobs = k2[I]/(Ki + [I])

(9)

The true equilibrium dissociation constant (Kc = k-1/k1) is subsequently
determined by equation 10 (Feaster and Quinn, 1997). [A] represents the
concentration of pNPV used in the assay (500 μM) and Km is obtained from the
enzymatic hydrolysis of pNPV in the absence of carbaryl.
Kc = Ki/(1 +[A]/Km)

(10)

The rate of enzyme decarbamylation (k3) is derived from the residual
velocity observed in carbaryl hydrolysis. In the linear steady-state phase of the
hydrolytic reaction denoted by vss, the rates of carbamylation and
decarbamylation are equal (Feaster et al., 1996). The term vss contains
contributions from both the non-enzymatic hydrolysis rate and from the turnover
of the carbamylated enzyme complex, which is determined by k3 (Figure 4).
When the non-enzymatic rate of pNPV hydrolysis is subtracted from vss, then
the residual velocity vr is a function of [I] (Equation 11). The terms v0, vmin, and
KmI are the rate in the absence of inhibitor, the rate at infinite inhibitor
concentration and Michaelis constant for carbaryl, respectively.
Vr = v0(KmI + vmin[I])/(KmI + [I])
24

(11)

By estimating KmI from Equation 11, the k3 rate constant of carbaryl hydrolysis
can be determined by use of equation 12.
KmI = Kc[k3/(k2/k3)]

(12)
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26

k1

E+S

Figure 3.

k-1

k2

ES

EA
+
P1

k3

E + P2

+ H2O

Carboxylesterase-mediated ester hydrolysis.

The reaction progresses by (i) non-covalent formation of the Michaelis
complex (ES), followed by (ii) acylation to form an acyl-enzyme intermediate
(EA) and the simultaneous formation of an alcohol product (P1). This
intermediate is (iii) deacylated by nucleophilic attack of a water molecule
producing a carboxylic acid product (P2) and recovering the enzyme.

E+C

Figure 4.

k1
k-1

k2
EC

EF
+
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k3 (slow)

E + P3

+ H2O

Carboxylesterase-mediated carbamate hydrolysis.

Hydrolysis occurs in an analogous fashion to ester hydrolysis.
Carbamates inhibit CEs due to the relatively slow decarbamylation (k3) of the
carbamylated-enzyme intermediate (EF). Hydrolysis of carbamates produces
an alcohol product (P1) and a carbamic acid product (P3)
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CHAPTER IV
RESULTS

Dual-luciferase assay
PXR –dependent activation of the CYP 3A4 promoter by rifampicin and
selected pyrethroids is shown in Figure 5. Similar to previous work (Lemaire et
al., 2004; Lehmann et al., 1998; Bertilsson et al., 1998), rifampicin exhibited a
PXR-dependent induction of luciferase gene expression when under the control
of a CYP 3A4 promoter. The PXR-dependence was verified by the lack of
rifampicin induction when PXR expression was absent (Figure 5). A significant
induction over DMSO vehicle control was observed with treatments of 10 µM
cis-permethrin, cypermethrin, deltamethrin, cyhalothrin and esfenvalerate. This
study demonstrates that several pyrethroids are potent PXR agonists similar to
the prototypical PXR ligand, rifampicin. Thus, pyrethroids can contribute to the
induction of xenobiotic metabolizing enzymes.

Expression and purification of pnb CE
Expression of pnb CE variants in E. coli resulted in robust protein
expression. Purification of CE proteins by preparative native PAGE yielded 6028

kDa proteins that were >90% pure, as determined by densitometric analysis of
Sypro Ruby-stained SDS-PAGE gels (Figure 6). Furthermore, digestion of
SDS-PAGE gel-purified wild type, L362R, and L362K pnb CEs with trypsin
followed by MALDI-TOF MS/MS analysis confirmed the presence of peptides
possessing mutant Arg and Lys residues at position 362 instead of Leu. Proper
folding of mutant CEs was verified by similar migration rates to wild type protein
in a native PAGE gels stained with 4-MUBA (Figure 7). Native PAGE gels
separate proteins based on both their charge and size, thus the expressed CEs
all appear to have similar charge and size and migrate in the native gel as
monomers.

pnb CE wild type and mutant kinetics
Three side-door mutants at position 362 containing a positively charged
residue (L362R), a negatively charged residue (L362E) or an aliphatic residue
(L362A) at position 362 were compared to wild type pnb CE for their ability to
hydrolyze several esters. The kinetic parameters obtained from the hydrolysis
of pNPV, 4-MUBA and trans-permethrin are illustrated in Figures 8 A-C. With
respect to Vmax values (Figure 8A), significant decreases from wild type levels
were observed for all substrates by the L362R mutant. In contrast, the L362E
and L362A mutants had a more complex effect on Vmax values, as indicated by
significant decreases for both with pNPV, with no significant difference in 4MUBA and trans-permethrin Vmax values. The Km parameters for wild type and
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mutant pnb CEs indicated only one significant difference, an increased Km for
the L362R mutant in pNPV hydrolysis (Figure 8B). The catalytic efficiencies
(kcat/Km) of the mutants followed a similar trend as the Vmax data. The L362R
mutant had significantly decreased catalytic efficiencies for all the substrates
compared to wild type (Figure 8C).

Organophosphate Inhibition
Differences between wild type and position 362 substituted mutants were
further investigated by inhibition studies with the active oxon form of three
common organophosphates: paraoxon (PO) methyl paraoxon (MPO) and
chlorpyrifos-oxon (CPO). Relative IC50 values for wild type pnb CE were
observed to be 1.32 nM, 80.9 nM and 0.57 nM for PO, MPO, and CPO
respectively (Table 1). This identified CPO and PO as being more potent
inhibitors compared to MPO. In contrast, the L362R mutant exhibited
significant increased IC50 values indicated by 2.4-, 3.3-, and 4.5-fold increases
for PO, MPO, and CPO, respectively (PO and MPO shown in Figure 9). The
increase in IC50 values indicates that L362R is less sensitive to inhibition by
organophosphate oxons than wild type enzyme. The L362A and L362D
mutants exhibited no significant difference in IC50 values with CPO and PO
inhibition compared to wild type. However, a significant decrease in IC50 for
MPO was observed with the L362A and L362D mutants (Table 1). According to
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these results, mutations at the side door are able to both increase and decrease
the sensitivity of an enzyme toward inhibition by organophosphate oxons.

pH-rate Profiles
pH–activity profiles for the L362R and wild type enzymes using the ester
substrate p-nitrophenyl laurate (pNPL) were examined (Figure 10). This was
done to determine if the L362R mutant alters the pKa of active-site residues.
The substrate pNPL was utilized in these pH studies because the nonenzymatic hydrolysis rate at pH >8.5 was negligible. In contrast, other
substrates, including pNPV and 4-MUBA, had significant non-enzymatic
hydrolysis rates at elevated pH (>8.5) and thus could not be used in the pH
activity experiments. For enzymatic reactions, the pH-dependence of Vmax
values can contribute to the elucidation of the catalytic mechanism by
determining which ionizable groups in the active site are important during
transition state stabilization (Turner et al, 2002). When Vmax values were
determined for wild type and L362R in buffers of various pH, no apparent
differences in pKa1 and pKa2 values were observed for the two enzymes. The
estimated pKa1 values for both wild type and L362R mutant was 7.3 ± 0.1
(Figure 10). Similarly, pKa2 values were estimated to be 10.0 ± 0.1 and 10.2 ±
0.1 for wild type and L362R pnb CE, respectively. The L362R mutation does
not appear to modulate the ionization potential of critical residues in the active
site involved in catalysis. Furthermore, it may be inferred that the orientation of
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the catalytic triad in the active site is not markedly changed in the mutant
enzyme compared to wild type because of the unaltered pKa1 values.
Viscosity variation
Examination of hydrolysis rates of several substrates in buffer solutions
of increasing viscosity were performed with wild type and mutant pnb CEs
(Figure 11). Plots of (kcat/Km)0/(kcat/Km) versus ηrel describe the diffusion
behavior of substrate at low substrate concentrations (Brouwer and Kirsch,
1982; Nakatani and Dunford, 1979). A slope of zero describes a non-diffusion
limited reaction and a slope of one corresponds to a reaction that is 100%
diffusion limited. Slopes of 1.39 ± 0.10, 0.78 ± 0.11, 0.76 ± 0.18, and 0.91 ±
0.16 for wild type, L362A, L362E and L362R pnb CE pNPV hydrolysis were
observed according to equation 6 and indicate that these reactions are to
various degrees limited by diffusion of substrate to the active site (Figure 11A,
Table 2). This is similar to the findings obtained with CPT-11 (Wierdl et al,
2004), where the second-order rate constants (kcat/Km) for wild type and L362R
pnb CE enzyme hydrolysis is controlled by diffusion. Therefore, at nonsaturating concentrations of pNPV the hydrolytic reaction appears to be
controlled by substrate diffusion for both wild type and mutant CEs. Due to an
upper limit for the slope of 1, the value of 1.39 for wild type pNPV hydrolysis
appears to be erroneous. A possible explanation for this is the data point at the
highest viscosity skewing the slope (Figure 11). Hydrolysis of trans-permethrin
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by wild type pnb CE also appears to be partially diffusion limited, as indicated
by a slope of 0.62 ± 0.20 (Table 2).
Using equation 6, the same viscosity-variation experiments allowed the
substrate association rate constant (k1) of pnb CE-catalyzed hydrolysis to be
obtained. With respect to pNPV hydrolysis, the most dramatic effect on k1 was
an observed 3.8-fold decrease for the L362R mutant compared to wild type
(Table 2). In contrast, the L362A and L362E mutants did not have substantial
differences in k1 values. This suggests that replacement of a hydrophobic
leucine residue at position 362 with the positively charged arginine residue
reduces the rate of substrate association with enzyme.
Plots of 1/kcat versus ηrel were also constructed according to equation 7
(Figure 11B). Similar to plots of catalytic efficiency (kcat/Km), the slopes
describe the dependence of diffusion on kcat at saturating levels of substrate.
Effects on kcat values due to increasing viscosity represent the dependence of
product diffusion on the reaction rate. In contrast to the second-order rate
constant (kcat/Km), the kcat parameter of pNPV hydrolysis was found to be partly
diffusion controlled for the wild type enzyme (slope = 0.49 ± 0.02) but not for
L362R (slope = 0.01 ± 0.14; Figure 11B). Thus, the reaction rate at saturating
concentrations of substrate (i.e., kcat) is partly diffusion-controlled for wild type
pnb CE, which suggests that the rate of product diffusion is partly limiting for the
wild type enzyme. In contrast, the L362R mutant does not appear to be limited
by product diffusion in pNPV hydrolysis.
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Because of the limitations of using viscosity variation data to determine
whether product release is a diffusion-limited process in a two-step reaction
mechanism (i.e., when two hydrolysis products, P1 and P2, are released in two
separate kinetic steps, Figure 3), we cannot infer from the above data whether
release of P1 or P2 limits the overall kcat for the wild type enzyme. As for the
L362R mutant, it can be concluded that kcat appears to be insensitive to the
presence of viscogen in the reaction buffer. Therefore, product release does
not limit the overall kcat for L362R. Since kcat is a complex function of both the
rates of acylation (k2) and deacylation (k3) [i.e., kcat = k2*k3/(k2+ k3)] (Hedstrom
et al, 2002; Equation 7), the L362R mutant has clearly decreased the
magnitude of either k2 or k3 (or both). The limitations of the viscosity variation
experiments prevent the quantification of these microscopic rate constants.
Nevertheless, for the hydrolysis of pNPV it is concluded that the L362R
mutation markedly affects the rate of substrate association with the enzyme
(i.e., k1) and has a detrimental effect on the rates of acylation and/or
deacylation.
As a control, we also investigated the hydrolysis rates of the smaller acyl
substrate pNPA by wild type pnb CE in increasing concentrations of viscogen.
In this case, we observed no change in the kcat/Km parameter as a function of
viscogen concentration. Therefore, the apparent dependence of kcat/Km on the
viscosity of the buffer solution (Figure 11A) is unlikely to be an artifact caused
by non-specific effects of sucrose on the CE enzyme. In further support of this,
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pNPV hydrolysis reactions catalyzed by wild type enzyme were also performed
in buffers containing the polymeric viscogen ficoll. In contrast to small
monomeric viscogens (such as sucrose), polymeric viscogens do not impede
the diffusion of small molecules, such as substrates or products (Mattei et al.,
1999). The presence of the polymeric ficoll did not influence the reaction rates
catalyzed by pnb CE, verifying the effects observed in viscose solutions were
diffusion driven.

Hydrolysis of substrates forming common acyl-enzyme intermediates
Investigation into two similar substrates, pNPA and oNPA, were
performed (Table 3). If hydrolysis of the acyl-enzyme intermediate is the ratelimiting step during the reaction, then substrates that have the same acyl group
but different alcohol leaving groups should have similar kcat values, as is the
case with pNPA and oNPA. These two compounds release different alcohols,
p-nitrophenol and o-nitrophenol, during the acylation step of the enzyme (k2),
but form an identical acetylated-enzyme intermediate. In the case where
deacylation (k3) is the rate-limiting step of pNPA and oNPA hydrolysis, the kcat
parameters would be identical. Experimentally, kcat of oNPA was determined to
be 3.4-fold less than that of pNPA. This same trend was observed with the
L362R mutant. This implies that deacylation of the enzyme is not rate limiting
for all esters, and that acylation of the enzyme can be rate limiting.
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Carbaryl inhibition
In order to obviate the limitations of the viscosity variation experiments
outlined above, we have subsequently utilized the carbamate insecticide
carbaryl to further dissect the k2 and k3 rate constants of the hydrolytic reaction.
This allowed us to determine how the L362R mutant affected specific kinetic
steps relative to the wild type enzyme. Carbaryl acts as a pseudo-substrate
inhibitor of serine hydrolase enzymes by carbamylating the catalytic serine
residue of CEs (Figure 4), which is analogous to the formation of the acylenzyme intermediate for ester substrates in Figure 3 (Mattei et al, 1999).
However, the turnover of the carbamylated intermediate EF (i.e., the
decarbamylation step k3) is much slower than the carbamylation step (k2).
Thus, the two steps of the reaction can be teased apart by performing
continuous spectrophotometric hydrolysis assays of pNPV hydrolysis in the
presence of variable concentrations of carbaryl (Feaster and Quinn, 1997).
Such experiments were performed (Figure 12) with wild type and L362R
enzymes and quantitatively determined both k2 and k3 (Table 4). It was
determined that the carbamylation step (k2) for the mutant L362R was reduced
two-fold compared to wild type enzyme (Table 4). Further, the magnitude of k3
for the L362R mutant was also reduced two-fold compared to wild type, thus the
ratio k2/k3 for both wild type and L362R were comparable (Table 4). Both
enzymes appeared to exhibit the same affinity for the carbaryl substrate as
evidenced by the similar Kc values (Table 4). A general conclusion that can be
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made from these data is that the L362R mutant appears to affect the
magnitudes of k2 and k3 to a similar degree. It is likely that acylation and
deacylation steps are both negatively affected by the introduction of the arginine
residue at position 362 during ester hydrolysis.
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The induction of luciferase activity following exposure to PXRspecific ligands in the dual luciferase assay.

Abbreviations are as follows: A, DMSO; B, rifampicin; C, rifampicin (w/o
PXR expression); D, bioresmethrin; E, trans-permethrin; F, 50/50 cis/transpermethrin; G, cis-permethrin; H, cypermethrin; I, deltamethrin; J, cyhalothrin;
K, esfenvalerate. Values are expressed as mean ± SE (n = 9). Significant
differences from DMSO treatments were determined by ANOVA (p<0.001)
followed by a post-hoc Tukey test.
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SDS-PAGE of all purified pnb CE variants.

Approximately 1.0 µg of total protein was loaded to each lane. Proteins
were visualized by staining with Sypro Ruby. Abbreviations for pnb Ces are as
follows: wt, wild type; A, L362A; V, L362V; D, L362D; E, L362E; K, L362K; R,
L362R; MM, m.w. marker.

Figure 7.

Native 4-MUBA in-gel hydrolysis by all purified pnb CE variants.

Approximately 1.0 μg of total protein per lane was used. Abbreviations
are identical as in Figure 6.
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Comparison of Vmax (A), Km (B) and kcat/Km (C) kinetic parameters
of pNPV, 4-MUBA and trans-permethrin hydrolysis by wild type
and Leu 362 substituted residues.

Values are expressed as mean ± SD of at least three independent
determinations of steady-state parameters. Significant differences from wild
type pnb CE indicated by (*), p < 0.05.
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Figure 8 (continued).
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trans-permethrin

Table 1.

IC 50 values (nM) of wild type or mutant pnb CE by various oxons
Organophosphate

Enzyme

PO

MPO

wild type

1.32 ± 0.09

80.9 ± 9.5

L362A

0.95 ± 0.09

18.1 ± 1.1

L362D

0.84 ± 0.30

23.5 ± 3.7

L362R

3.11 ± 0.32

a

CPO
0.57 ± 0.23

a

1.67 ± 0.32

a

2.32 ± 0.73

a

269.7 ± 29.0

a

a

Values are represented as mean ± SE of two to four replications.
a

Significant differences from wild type pnb CE (p<0.05).
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a

2.55 ± 0.28
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Fractional Inhibition
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Figure 9.

Inhibition of wild type (black symbols) and L362R (white symbols)
pnb CE-mediated pNPV hydrolysis by the oxons of parathion
(●,○), and methyl parathion (■,□).

The L362R mutant exhibits a decrease in sensitivity toward both PO and
MPO as shown by 2.4- and 3.3-fold increases in IC50 values, respectively,
compared to wild type pnb. Error bars have been omitted to simplify the graph.
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Figure 10.

pH dependence of the Vmax parameter of wild type (A) and L362R
(B) pnb CE.

Vmax values were estimated from the CE-catalyzed hydrolysis of pNPL.
Dashed lines were obtained by fitting the experimental data to Equation 1. Data
points are the mean ± S.D. of three replications.
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Figure 11.

Influences of viscosity on both wild type and L362R pnb CE
hydrolysis of pNPV and pNPA.

Measurements of wild type pnb CE (●) and L362R (▼) hydrolysis with
pNPV as a substrate. Wild type pnb CE hydrolysis with pNPA (■) as a
substrate. (A) Normalized catalytic efficiency (kcat/Km) versus relative viscosity;
slope = (kcat/Km)0/k1. (B) Normalized turnover number (kcat) versus relative
viscosity; slope = kcat0/kcat. Data points are represented by the mean ± SD of
two to four independent determinations of the kinetic parameters.
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Table 2.

Experimental kinetic parameters and derived rate constants for
wildtype and mutant pnb CE hydrolysis of several substrates.
-1 -1

Substrate

wt

p NPV

4.3 x 10

L362A

p NPV

1.2 x 10

L362E

fold

kcat/Km (M s )

Enzyme

-1

-1

1

2.3 x 10

6

3.6

2.7 x 10

2.6 x 10

1.7

fold

k1 (M s )

6

6

p NPV

a

a

Slope

6

1

1.39

6

0.9

0.78

6

0.5

0.76

6

3.8

0.91

6

4.3 x 10

6

8.6

0.6 x 10

6

b

L362R

p NPV

0.5 x 10

wt

p NPA

2.7 x 10

---

2.7 x 10

0.9

0.003

206

---

380

6050

0.62

wt

t- perm

c

The kinetic parameters are expressed in mean ± SD.
a

Fold difference in values compared to wild type pnb CE pNPV hydrolysis.

b

Slope of (kcat/Km)0/(kcat/Km) versus ηrel.

c

Abbreviation for trans-permethrin.

Table 3.

Kinetic parameters of o- and p-nitrophenyl acetate hydrolysis by
wild type pnb CE.
o-nitrophenyl acetate

p-nitrophenyl acetate
-1

-1

Enzyme

K m (μM)

k cat (s )

K m (μM)

k cat (s )

wild type

365 ± 46

48.2 ± 2.6

412 ± 50

165.5 ± 8.9

Table 4.

Kinetic parameters of carbary inhibition of wild type and L362R
pnb CE.
-1

Enzyme

Kc (μM)

k2 (s )

fold

wild type

7.5

0.018

L362R

6.5

0.0084

a

a

-1

a

k3 (s )

fold

1

0.00031

1

58

2.1

0.00015

2.1

56

Fold decrease in kinetic parameters compared to wild type.
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Figure 12.

Continuous assay of pNPV hydrolysis by wild type (A) and L362R
(B), in the presence of various concentrations of carbaryl.

The biphasic nature of both wild type and L362R enzyme at > 400 sec in
the absence of carbaryl may be due to the combination of substrate depletion
after 5 min of pNPV hydrolysis and partial enzyme denaturation during the
assay period at 37° C
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CHAPTER V
DISCUSSION

Carboxylesterases are highly expressed in several tissues and exhibit
hydrolytic activity toward a diverse array of substrates. For several xenobiotics
including pyrethroids, CE-mediated hydrolysis is a significant metabolic route.
Human exposure to pyrethroids continues to rise as the use of pyrethroids in
agricultural practices continues to grow. Therefore, the ability of CEs to detoxify
these compounds becomes an important mechanism of their clearance. This
study has shown the ability of several pyrethroids to activate the promoter of
CYP 3A4, demonstrating the ability of these compounds to contribute to
pesticide-pesticide or pesticide-drug interactions. It appears that the difference
in induction potency among the pyrethroids is related to their metabolism in Hep
G2 cells. These cells express hCE1 protein at appreciable levels (unpublished
data). Hep G2 lysate activity toward various pyrethroids showed bioresmethrin
and trans-permethrin to be hydrolyzed at appreciable rates, while no hydrolysis
of the other pyrethroids were observed (unpublished data). Consistent with
this, mammalian CEs have been shown to preferentially hydrolyze both
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bioresmethrin and trans-permethrin at substantially higher levels than cispermethrin, deltamethrin and cypermethrin (Ross et al., 2006). Therefore, the
hydrolytic activity of CEs may relate directly to the potency of pyrethroids as
xenobiotic metabolizing enzyme inducers.
Currently, the role of the side-door in CE enzymes is not fully
understood. Several structural domains in CEs add to this enzyme’s
promiscuity and flexibility, including a large conformable substrate binding
pocket and an alternate pore (i.e. side-door) that may permit compounds to
enter or exit the active site (Bencharit et al., 2002; Bencharit et al., 2006). Our
current study demonstrates that mutation of the gate residue at the side-door
markedly influences the kinetic parameters of hydrolysis, including substrate
association and chemical bond making/breaking steps. This study further
implicates the importance of the side-door in CE catalysis and suggests that
future studies should be extended to the mammalian enzymes.
Previous work indicated that mutation of Leu 362 to an Arg residue in
pnb CE significantly reduced the rate of hydrolysis of both oNPA and CPT-11
(Wierdl et al., 2004). We have extended these findings by examining six
different amino acid substitutions at Leu 362, including two positively charged
(L362D, L362E), two negatively charged (L362K, L362R), and two neutral and
aliphatic (L362A and L362V) residues for activity toward pNPV, 4-MUBA, transpermethrin and selected OP oxons. Initial study revealed that differences in
hydrolytic activity correlated strongly with the charge of the mutant residue;
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therefore, subsequent studies focused on only one mutant residue from each
charge group (i.e. L362A, L362E, L362R).
Examination of the kinetic parameters clearly demonstrates that the most
detrimental effect on enzyme activity was caused by the positively charged
mutant (L362R). In contrast the aliphatic (L362A) and negatively charged
(L362E) substitutions, did not exhibit as pronounced effects on activity (Figure
8). The significant differences in Vmax and Km values for L362R pnb CEcatalyzed hydrolysis of pNPV indicates that mutation at position 362 can affect
the affinity between enzyme and substrate and catalytic steps, which agrees
with previous observations with the substrate CPT-11 (Wierdl et al., 2004).
Our results also demonstrated that site-specific mutations at position 362
could alter the sensitivity of pnb CE toward organophosphate oxon inhibition.
Organophosphate oxons irreversibly inhibit the catalytic Ser residue of serine
hydrolases, such as CEs (Aldridge, 1993). The potency of the individual oxons
in our study correlates well with previous observations of rat liver esterase
inhibition by these same compounds (Atterberry et al., 1997). Thus, pnb CE
has the potential to be used as a model enzyme for studying inhibition by
organophosphate oxons and to rationally design efficient OP hydrolases. An
interesting observation was the variable sensitivity of Leu 362 mutants toward
MPO (Table 1) compared to wild type enzyme. Specifically, L362A and L362D
had decreased IC50 values (i.e., an increase in inhibition sensitivity) while
L362R exhibited an increased IC50 value (a decrease in inhibition sensitivity). A
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similar but non-significant trend was also observed with PO. However, no clear
explanation at present exists for these differences in MPO/PO inhibition. A
general observation is that L362R is both catalytically inefficient toward
carboxylic esters and inefficiently inhibited by OP oxons when compared to wild
type enzyme. It appears that the mutated gate residue is affecting the reactivity
of the Ser residue and/or access of the substrate to the active site.
Further studies were conducted to account for the altered kinetic
parameters between wild type and L362R pnb CE. It was initially hypothesized
that the decreased catalytic rate for L362R pnb CE was due to disruption of the
active site catalytic triad, thus potentially affecting the nucleophilicity of the
active site Ser residue. The residues that compose the side-door are in close
spatial proximity to the catalytic triad and a mutation at position 362 may affect
the spatial arrangement of ionizable groups that are critical for stabilizing the
transition state of the rate-determining step. Data obtained from the pH-activity
experiments indicated that two ionizable groups (pKa1 and pKa2) were present in
the active site of the wild type and L362R variant. However, no apparent
difference in pKa values were observed between the wild type and L362R
variant, thus the ionizable residues involved in stabilizing the transition state do
not appear to be affected by mutation of the side-door gate residue. The pKa1
value in serine hydrolase enzymes is dominated by the pKa of the Nε atom on
the catalytic histidine residue (Stok et al., 2004), while pKa2 is likely due to
ionization of an amino acid residue involved in the stabilization of the oxyanion
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intermediate (Turner et al., 2002). The Nε atom of the active site histidine in
serine proteases typically has a pKa ranging from 5.5-8.0 (Fersht, 1998), which
is likely reflected by the observed pKa1 (=7.3) in both the wild type and L362R
mutant in our study. Previous studies of the pH-rate profiles for the rat
carboxylesterase, Hydrolase A, and a bacterial cocaine esterase have also
attributed the first pKa1 to the histidine residue in the active site (Turner et al.,
2002; Stok et al., 2004). Therefore, the L362R mutant does not appear to affect
the ionizable potential of critical residues in the active site involved in
biotransforming substrates to products. Furthermore, it may be inferred that the
orientation of the catalytic triad in the active site is not markedly changed in the
mutant enzyme compared to wild type.
For a more complete mechanistic understanding of the altered kinetics
attributable to the side-door mutant, enzymatic assays were performed in the
presence of a viscogen. By increasing the viscogen concentration and
observing the effects on enzymatic reaction rates, the extent to which diffusive
processes impinge on enzymatic rates can be made (Brouwer and Kirsch,
1982). All enzyme and substrate combinations, except the wild type pnb CE
hydrolysis of pNPA, were markedly dependent on substrate diffusion rates into
the active site (Table 2). Thus, it appears that hydrolysis rates for substrates
possessing bulky acyl groups are limited by substrate diffusion. This might be
attributed to the relative difficultly in fitting bulky acyl groups within the catalytic
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gorge and the facile binding of substrates containing a small acetyl group (e.g.,
pNPA and oNPA) (Wierdl et al., 2004).
Gate residues of the side-door have been observed to directly interact
with ligands in the active site, implying the possibility that ligand affinity can be
affected by this residue (Bencharit et al., 2003). The 4-fold reduction in the
substrate association rate (k1) during L362R-mediated hydrolysis of pNPV
indicates that mutation at the side-door can affect non-covalent binding of
pNPV. This result is also consistent with the fact that no differences in Km
values for pNPV hydrolysis were observed with the negatively charged (L362E)
and aliphatic (L362A) mutants, while an increased Km was noted for the L362R
mutant (Figure 8B). However, no alterations in Km values for 4-MUBA and
trans-permethrin were observed with L362R pnb CE, suggesting that substrate
affinity was not adversely affected for these substrates. The decrease in
substrate association could be attributed to electrostatic repulsion between the
Arg362 and positively charged regions of ester substrates. These results are
consistent with previous work. In studies of irinotecan hydrolysis catalyzed by
pnb CE enzymes (Wierdl et al., 2004) cleavage of the pro-drug by wild type and
L362R enzymes was limited by the rate of substrate diffusion. Moreover,
quantitative viscosity variation analysis (Nakatani and Dunford, 1979)
demonstrated that k1 was reduced 137-fold for the L362R mutant compared to
wild type enzyme, suggesting that a greater energy cost prevails for the binding
of CPT-11 to L362R, compared to wild type (Wierdl et al., 2004).
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The efficiency of the bond making/breaking steps (k2 and k3) during
pNPV hydrolysis by wild type pnb CE is so efficient that product diffusion
becomes partially limiting at saturating concentrations of substrate (Figure 11B).
This was in marked contrast to viscosity-variation experiments with L362R pnb
CE, which indicated that kcat was not influenced by increasing viscogen
concentration. Viscosity experiments cannot absolutely determine whether the
release of P1 (alcohol metabolite) or P2 (carboxylic acid metabolite) limits the
overall rate (kcat) of pnb CE-catalyzed hydrolysis of pNPV. This finding does
argue against a scenario in which the positively charged arginine residue
interacts with negatively charged carboxylic acid metabolites, retaining them at
the side-door domain and preventing enzyme turnover. Future pre-steady state
experiments may shed light on the specific step that is limiting the wild type
enzymatic rate.
Nevertheless, these results clearly showed that the L362R
mutation limits the catalytic steps to such a degree that diffusion of product from
the enzyme is no longer rate-limiting (Figure 11B). Therefore, the ~8-fold
decrease in kcat observed with L362R compared to wild type pnb CE is due to a
decrease in the magnitude of k2 and/or k3. Since kcat is a complex function of
the rates of acylation (k2) and deacylation (k3) (Equation 7), it cannot be
determined whether k2, k3 or both are affected in the L362R mutant. However,
because the maximal hydrolysis rates of pNPA and oNPA (kcat) are different
(Table 3) this suggests that hydrolysis of each substrate, which produces a
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common acetyl-enzyme intermediate, has a different rate-limiting step than
deacylation (i.e., the acylation of the enzyme). Therefore, it is likely that the
decreased rate of acylation of the L362R enzyme by pNPV results in the
observed decrease in kcat.
The use of the pseudo-substrate inhibitor carbaryl allowed further
mechanistic insight into the catalytic differences between wild type and L362R
enzymes. Carbamates are hydrolyzed by a similar mechanism as carboxylic
esters (Figures 3 and 4), thus the carbamylation and decarbamylation steps are
analogous to the acylation and deacylation of ester hydrolysis. However,
carbamates are considered to be pseudo-substrate inhibitors because of the
relatively slow decarbamylation step compared to the carbamylation rate
(Feaster and Quinn, 1997). Slow decarbamylation of CE enzyme was indeed
observed in our study, with a k2/k3 ratio >50 for the wild type and L362R pnb
CEs. However from our kinetic studies it was apparent that the L362R mutation
negatively influenced both the rates of carbamylation and decarbamylation
(Table 4). The L362R mutant did not affect carbaryl affinity toward the active
site (Kc), which again describes the substrate-specific effects observed
elsewhere in this study with Km values (Figure 8B).
Overall, this study showed that residues at the side-door are able to
affect multiple parameters of CE-catalyzed hydrolysis. Both the rate of
substrate association (k1) and chemical bond making or breaking steps (k2 and
k3) are compromised by mutations at the side-door. Electrostatic effects may
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partly explain the altered substrate affinity toward the mutant enzyme.
However, from the pH-activity experiments it does not appear that the active
site charge relay system (catalytic triad) is altered in such manner that it affects
the chemical bond making or breaking steps. An alternative proposal may be
that the shape of the active site in the mutant enzyme is altered thereby causing
a greater degree of steric hindrance, which has the effect of increasing the
distance between the oxygen of the active site Ser residue and carbonyl carbon
of the substrate. Such a scenario would account for the observed reduced
rates in forming the tetrahedral intermediate (k2) in both ester and carbaryl
hydrolysis, and also the decrease in OP inhibition in the mutant L362R enzyme
compared to wild type.
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